Dashboard
Discover upcoming research grants.
Discover upcoming research grants.
The NCI offers SBIR Phase IIB Bridge Awards to advance cancer technologies towards commercialization by providing additional funding for projects that have already received Phase II awards to support their transition to the commercialization stage, promoting partnerships with third-party investors, and requiring a Commercialization Plan that includes details on secured or anticipated third-party investor funding.
NIAID offers funding for small businesses to conduct clinical trials related to its research mission, particularly encouraging high-risk studies involving non-routine interventions or administration of unlicensed products for unapproved indications.
Funding for small businesses to conduct clinical trials focused on neurological disorders, including drugs, devices, therapies, and diagnostics; SBIR Phase II and Fast-Track applications only.
Explore new technologies for semiconductor metrology with the SBIR CHIPS For America program, enhancing U.S. leadership in the industry.
This grant supports small businesses conducting early-stage clinical trials for vision disorder interventions, with high risk and the need for safety monitoring. Proper consultation is recommended before submitting.
Develop digital science resources for students & teachers to promote biomedical education in pre-college, for small businesses.
Funding for developing products/processes/services to improve minority health and reduce health disparities in the US through SBIR grants.
The SSBCI Investing in America SBOP grant seeks innovative models for providing technical assistance to VSBs & SEDI-owned businesses, supporting small business access to capital and job creation post-pandemic.
NINDS provides funding for Small Business Concerns to conduct clinical trials on neurological products in line with their mission and goals.
This grant supports small businesses in the transition of SBIR/STTR projects to the commercialization stage, providing additional support for technical assistance, late-stage R&D, and at least 1 clinical trial, aligning with the goals of participating NIH Institutes and Centers.